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BAX/BAK activation leading to mitochondrial outer-membrane permeabilization is a key commit-
ment point in apoptosis. Chipuk et al. now identify two sphingolipids as specific cofactors
for BAX/BAK activation that lower the threshold for apoptosis-associated cytochrome c release.
Association of mitochondria with other cellular membrane compartments is required for BAK/
BAX exposure to these sphingolipids.BAX/BAK activation is a major checkpoint
in apoptosis, as this event irreversibly
commits the majority of cells to die
(Llambi et al., 2011). Upon activation,
BAX and BAK oligomerize within the
mitochondrial outer membrane, resulting
in the formation of a pore or channel that
promotes release of cytochrome c and
many other proteins from the mitochon-
drial intermembrane space. This process
is known as mitochondrial outer-mem-
brane permeabilization (MOMP). In the
cytosol, cytochrome c acts as a cofactor
for the assembly of a caspase-activating
complex called the apoptosome, which
triggers a proteolytic cascade that co-
ordinates cell destruction typical of
apoptosis. In addition, MOMP causes
mitochondria to rapidly depolarize and
lose their capacity to generate ATP, which
also proves fatal for the majority of cells,
irrespective of whether the apoptosome
is activated downstream. Much effort
has therefore been directed toward
understanding BAX/BAK oligomerization
and the factors that promote or oppose
BAX/BAK-dependent MOMP. In this
issue of Cell, Chipuk et al. report that
the sphingolipid metabolites, sphingo-
sine-1-phosphate and hexadecenal, act
as cofactors for BAK and BAX activation,
respectively (Chipuk et al., 2012).
BAX/BAK oligomerization within the
mitochondrial outer membrane is typically
initiated due to stress or damage that
activates one or more members of the
BH3-only subset of the Bcl-2 family (Youle
and Strasser, 2008). BH3-only proteins
serve as pathway-specific stress sensors
that promote activation of BAX and/orBAK either through direct interaction
with the latter proteins or through binding
and neutralizing BAX/BAK antagonists
such as Bcl-2 and its close relatives (Letai
et al., 2002; Llambi et al., 2011). Recent
studies suggest that extensive contacts
exist between mitochondria and other
membrane compartments, such as the
ER, which facilitates the transfer of
calcium as well as lipids between these
organelles and can influence signal
propagation within the cell (de Brito and
Scorrano, 2008). To explore the factors
that influence the threshold for MOMP,
Chipuk et al. compared the efficiency of
BH3-only protein-induced BAK activation
in mitochondrial preparations containing
diverse membranes, including those
from the ER and other membrane com-
partments, with highly purified mito-
chondria free of heterotypic membranes
(Chipuk et al., 2012). BAK activation was
greatly compromised in the highly pure
mitochondrial preparations when com-
pared with mitochondria containing ER
and other microsomal membranes.
To parse out which components of
the heterotypic membranes facilitated
BAK activation, the authors carried out
fractionations and identified two neutral
sphingomyelinases (SMases) enriched
in a subfraction capable of restoring
sensitivity to MOMP in purified mito-
chondria (Chipuk et al., 2012). Moreover,
addition of purified neutral SMase was
sufficient to restore sensitivity to BH3-
only protein-induced BAK activation.
SMases hydrolyze sphingomyelin to
ceramide, a lipid that has previously
been implicated as a second messengerCell 1in apoptosis, although the mechanistic
basis for the proapoptotic effects of
ceramide has been debated (Taha et al.,
2006). Ceramide can undergo further
conversion to sphingosine and sphingo-
sine-1-phosphate (S1P) through the
actions of ceramidase and sphingosine
kinase, respectively. Using a panel of
enzymes and inhibitors to walk down
the sphingomyelin hydrolysis pathway,
Chipuk et al. identified S1P and its
breakdown product, hexadecenal (Hex),
as factors that can promote BAK
and BAX oligomerization, respectively.
Furthermore, manipulation of sphingolipid
metabolism in cells either by overexpres-
sion of neutral SMases or by knocking
down a mitochondrial-associated sphin-
gosine kinase (SPHK2) required for
S1P production led to sensitization or
protection from apoptosis, respectively
(Chipuk et al., 2012).
Collectively, these observations sug-
gest that mitochondria-associated or-
ganelles, such as the ER, can influence
the set point for apoptosis through tonic
provision of sphingolipids tomitochondria
that influence BAX/BAK oligomerization
thresholds (Figure 1). Although the SMase
activity required for ceramide generation
appears to reside in a mitochondrial-
associated membrane compartment,
further conversion of ceramide through
to S1P and Hex is likely to occur within
mitochondrial membranes (Chipuk et al.,
2012). Although sphingomyelin pathway
metabolites have been implicated in
apoptosis in many previous studies
(Taha et al., 2006), a consensus view on
how these lipids influence apoptosis has48, March 2, 2012 ª2012 Elsevier Inc. 845
Figure 1. Sphingolipids Lower the Threshold for BAX and BAK Activation
Mitochondrial-associated membrane compartments contain sphingomyelinases (SMases) that provide
sphingolipids to mitochondria. SMases convert sphingomyelin to ceramide, which can be further
converted to sphingosine via ceramidase activity. Sphingosine kinase activity converts sphingosine to
S1P, which can be converted to hexadecenal (Hex) via S1P lyase. Note that reverse flux from S1P to
sphingomyelin is also possible. Hex binds specifically to BAX and promotes BAX oligomerization upon
exposure to BH3-only proteins, whereas S1P promotes BAK oligomerization upon BH3-only exposure. Its
specific binding to BAK has not yet been explored. Oligomerization of either BAK or BAX results in
cytochrome c (Cyt c) release; only a BAK complex is shown here for simplicity.been lacking. The present study suggests
that sphingolipids function to provide the
correct milieu within mitochondrial outer
membranes that permits efficient BH3-
only protein-initiated BAX/BAK oligomeri-
zation (Figure 1). Thus, forward or reverse
flux through the sphingolipid pathway
may increase or decrease the threshold
for apoptosis by altering the levels of
S1P and Hex that are available for BAK
and BAX binding.
But specifically, how do Hex and S1P
lower the threshold for BAX/BAK activa-
tion? Oligomerization of BAX and BAK
is associated with major conformational
changes within their N termini that expose
BH3 domains and permit interaction
with the surface hydrophobic grooves of
a neighboring BAX or BAK molecule
(reviewed in Dewson and Kluck, 2009).
Additional ‘‘back-to-back’’ interactions
between BAX or BAK dimers promote
further oligomerization to form pores that
permit efflux of mitochondrial constitu-
ents (Dewson and Kluck, 2009). Although
Chipuk et al. did not explore this issue
beyond demonstrating that Hex can
selectively bind to BAX and facilitate a
conformational change typically observed
at the onset of MOMP, it seems reason-
able to propose that BAX and BAK
contain lipid-binding pockets that, when
occupied, lower the energetic constraints
required to undergo these transitions.846 Cell 148, March 2, 2012 ª2012 Elsevier IAlternatively, S1P- and Hex-enriched mi-
crodomains may exist on mitochondrial
outer membranes that permit more effi-
cient assembly of BAX or BAK oligomers
within these regions.
With regard to the possibility of direct
binding of S1P or Hex to BAK and BAX,
it is noteworthy that a recent study identi-
fied a recognition sequence for sphingo-
myelin 18 within the transmembrane
domain of the COPI machinery protein
p24, which resides within the membrane
of Golgi-derived vesicles (Contreras
et al., 2012). Sphingomyelin binding to
p24 regulated its propensity to switch
from a monomeric (inactive) to an oligo-
meric (active) state (Contreras et al.,
2012). Thus, in addition to fulfilling struc-
tural roles within cell membranes, sphin-
golipids may serve as exquisitely specific
cofactors for membrane proteins that
regulate the activation state of such
molecules. In future studies, it will be
interesting to explore whether BAX or
BAK have similar sphingolipid-binding
domains.
Interestingly, studies have also sug-
gested that S1P production is increased
during apoptosis and, upon secretion,
helps to guide phagocytes toward dying
cells to facilitate their swift removal
from tissues (Weigert et al., 2010; Gude
et al., 2008). S1P accumulation during
apoptosis has been reported to be duenc.to upregulation of the sphingosine kinase
SPHK1, as well as caspase-dependent
proteolysis of SPHK2 (Gude et al., 2008;
Weigert et al., 2010). It is tempting to
speculate that SPHK activation, leading
to S1P generation, may kill two birds
with one stone during apoptosis. On the
one hand, increased S1P production
may lower the threshold for BAK activa-
tion, and on the other, S1P secretion
may help to coordinate the safe disposal
of the dying cell through acting as
a ‘‘find me’’ signal for phagocytes.
Understanding the mechanics of BAX/
BAK activation has proved challenging,
and important questions clearly remain.
The precise composition and structure
of the fully assembled BAX/BAK mito-
chondrial channel await definition. It is
also unclear whether this channel is
comprised solely of BAX and/or BAK or
contains additional constituents. How-
ever, the discovery that BAX and BAK
activation is regulated by sphingolipids
may go some way toward explaining
why unraveling the intricacies of MOMP
has proven to be quite a slippery task.REFERENCES
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